These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
181 related items for PubMed ID: 36001225
1. Synthesis, antileishmanial activity and molecular modeling of new 1-aryl/alkyl-3-benzoyl/cyclopropanoyl thiourea derivatives. Mohammadi-Ghalehbin B, Shiran JA, Gholizadeh N, Razzaghi-Asl N. Mol Divers; 2023 Aug; 27(4):1531-1545. PubMed ID: 36001225 [Abstract] [Full Text] [Related]
2. Thiourea-functionalized aminoglutethimide derivatives as anti-leishmanial agents. Sajid M, Siddiqui H, Zafar H, Yousuf S, Threadgill MD, Choudhary MI. Future Med Chem; 2024 Aug 02; 16(15):1485-1497. PubMed ID: 38953461 [Abstract] [Full Text] [Related]
3. Synthesis, antimicrobial, antioxidant, cytotoxic, antiurease and molecular docking studies of N-(3-trifluoromethyl)benzoyl-N'-aryl thiourea derivatives. Maalik A, Rahim H, Saleem M, Fatima N, Rauf A, Wadood A, Malik MI, Ahmed A, Rafique H, Zafar MN, Riaz M, Rasheed L, Mumtaz A. Bioorg Chem; 2019 Jul 02; 88():102946. PubMed ID: 31054433 [Abstract] [Full Text] [Related]
4. Synthesis, molecular modeling and biological screening of some pyrazole derivatives as antileishmanial agents. Bekhit AA, Saudi MN, Hassan AM, Fahmy SM, Ibrahim TM, Ghareeb D, El-Seidy AM, Al-Qallaf SM, Habib HJ, Bekhit AEA. Future Med Chem; 2018 Oct 01; 10(19):2325-2344. PubMed ID: 30215271 [Abstract] [Full Text] [Related]
5. Antileishmanial Thioureas: Synthesis, Biological Activity and in Silico Evaluations of New Promising Derivatives. Viana GM, Soares DC, Santana MV, do Amaral LH, Meireles PW, Nunes RP, da Silva LCRP, Aguiar LCS, Rodrigues CR, de Sousa VP, Castro HC, Abreu PA, Sathler PC, Saraiva EM, Cabral LM. Chem Pharm Bull (Tokyo); 2017 Oct 01; 65(10):911-919. PubMed ID: 28966275 [Abstract] [Full Text] [Related]
6. Design, synthesis, and in vitro biological evaluation of novel thiazolopyrimidine derivatives as antileishmanial compounds. Istanbullu H, Bayraktar G, Akbaba H, Cavus I, Coban G, Debelec Butuner B, Kilimcioglu AA, Ozbilgin A, Alptuzun V, Erciyas E. Arch Pharm (Weinheim); 2020 Aug 01; 353(8):e1900325. PubMed ID: 32484266 [Abstract] [Full Text] [Related]
7. Molecular Dynamics Simulation and Docking Studies of Selenocyanate Derivatives as Anti-Leishmanial Agents. Iman M, Kaboutaraki HB, Jafari R, Hosseini SA, Moghimi A, Khamesipour A, Harchegani AB, Davood A. Comb Chem High Throughput Screen; 2016 Aug 01; 19(10):847-854. PubMed ID: 27604957 [Abstract] [Full Text] [Related]
8. Antileishmanial activity of Riparin structural analogs of Aniba riparia: Biological evaluation, in silico Adme-Tox, and molecular docking. Figueiredo KA, Magalhães Costa RK, Rocha JA, Chavez Gutierrez SJ, Ramos RM, Muálem de Moraes Alves M, Aécio de Amorim Carvalho F, Menezes Carvalho AL, Lima FDCA. Exp Parasitol; 2022 Aug 01; 236-237():108257. PubMed ID: 35398101 [Abstract] [Full Text] [Related]
10. Tetrahydrobenzo[h]quinoline derivatives as a novel chemotype for dual antileishmanial-antimalarial activity graced with antitubercular activity: Design, synthesis and biological evaluation. Ibrahim TM, Abada G, Dammann M, Maklad RM, Eldehna WM, Salem R, Abdelaziz MM, El-Domany RA, Bekhit AA, Beockler FM. Eur J Med Chem; 2023 Sep 05; 257():115534. PubMed ID: 37269671 [Abstract] [Full Text] [Related]
11. Synthesis and antileishmanial effect of a few cyclic and non-cyclic n-aryl enamino amide derivatives. Mohammadi-Ghalehbin B, Najafi S, Razzaghi-Asl N. Res Pharm Sci; 2020 Aug 05; 15(4):340-349. PubMed ID: 33312212 [Abstract] [Full Text] [Related]
12. Syntheses, in vitro urease inhibitory activities of urea and thiourea derivatives of tryptamine, their molecular docking and cytotoxic studies. Kanwal, Khan M, Arshia, Khan KM, Parveen S, Shaikh M, Fatima N, Choudhary MI. Bioorg Chem; 2019 Mar 05; 83():595-610. PubMed ID: 30513472 [Abstract] [Full Text] [Related]
14. Synthesis of Thiocarbohydrazones and Evaluation of their in vitro Antileishmanial Activity. Muhammad MT, Ghouri N, Khan KM, Arshia, Choudhary MI, Perveen S. Med Chem; 2018 Mar 05; 14(7):725-732. PubMed ID: 29332596 [Abstract] [Full Text] [Related]
15. Synthesis and Biological Evaluation of Tetrahydropyrimidine and Dihydropyridine Derivatives Against Leishmania Major. Jeddi B, Saberi S, Menéndez JC, Sepehri S. Acta Parasitol; 2022 Mar 05; 67(1):255-266. PubMed ID: 34279776 [Abstract] [Full Text] [Related]
17. Novel coumarin-isatin hybrids as potent antileishmanial agents: Synthesis, in silico and in vitro evaluations. Khatoon S, Aroosh A, Islam A, Kalsoom S, Ahmad F, Hameed S, Abbasi SW, Yasinzai M, Naseer MM. Bioorg Chem; 2021 May 05; 110():104816. PubMed ID: 33799180 [Abstract] [Full Text] [Related]
18. Synthesis and evaluation of novel triazolyl quinoline derivatives as potential antileishmanial agents. Upadhyay A, Kushwaha P, Gupta S, Dodda RP, Ramalingam K, Kant R, Goyal N, Sashidhara KV. Eur J Med Chem; 2018 Jun 25; 154():172-181. PubMed ID: 29793211 [Abstract] [Full Text] [Related]
19. Novel 5-(nitrothiophene-2-yl)-1,3,4-Thiadiazole Derivatives: Synthesis and Antileishmanial Activity against promastigote stage of Leishmania major. Sadat-Ebrahimi SE, Mirmohammadi M, Mojallal Tabatabaei Z, Azimzadeh Arani M, Jafari-Ashtiani S, Hashemian M, Foroumadi P, Yahya-Meymandi A, Moghimi S, Moshafi MH, Norouzi P, Kabudanian Ardestani S, Foroumadi A. Iran J Pharm Res; 2019 Jun 25; 18(4):1816-1822. PubMed ID: 32184848 [Abstract] [Full Text] [Related]